We visited Summit, New Jersey for a State of the Science Summit on non–small cell lung cancer. The meeting covered the current standard of care for early-stage lung cancer, approaches to locoregionally advanced NSCLC, updates in EGFR-positive NSCLC, emerging biomarkers, new data surrounding immunotherapy combinations, updates in squamous NSCLC, and advances in small cell lung cancer.
